Mark Klinger is an experienced professional in the field of cellular research, currently serving as VP of Cellular Research at Adaptive Biotechnologies Corp. since January 2015, where Mark has also held roles as Director of TCR Discovery and Principal Scientist. Previously, Mark was a Senior Scientist at Sequenta from November 2010 to January 2015 and an Immunologist at UCSF from December 2002 to January 2011, focusing on the immune system's development and response to infection while designing innovative tools for immune cell identification. Mark began their career as a Research Technician at the British Columbia Cancer Research Center in early 1997. Mark Klinger holds a PhD in Medical Genetics and a BSc in Biology, both from The University of British Columbia.